Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 105

1.

Predictive factors for lumacaftor/ivacaftor clinical response.

Masson A, Schneider-Futschik EK, Baatallah N, Nguyen-Khoa T, Girodon E, Hatton A, Flament T, Le Bourgeois M, Chedevergne F, Bailly C, Kyrilli S, Achimastos D, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

J Cyst Fibros. 2018 Dec 27. pii: S1569-1993(18)30821-X. doi: 10.1016/j.jcf.2018.12.011. [Epub ahead of print]

PMID:
30595473
2.

Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?

Pranke I, Hatton A, Masson A, Flament T, Le Bourgeois M, Chedevergne F, Bailly C, Urbach V, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):123-126. doi: 10.1164/rccm.201808-1436LE. No abstract available.

PMID:
30326728
3.

Structure-guided combination therapy to potently improve the function of mutant CFTRs.

Veit G, Xu H, Dreano E, Avramescu RG, Bagdany M, Beitel LK, Roldan A, Hancock MA, Lay C, Li W, Morin K, Gao S, Mak PA, Ainscow E, Orth AP, McNamara P, Edelman A, Frenkiel S, Matouk E, Sermet-Gaudelus I, Barnes WG, Lukacs GL.

Nat Med. 2018 Nov;24(11):1732-1742. doi: 10.1038/s41591-018-0200-x. Epub 2018 Oct 8.

PMID:
30297908
4.

Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.

Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, Davy N, Bismuth E, Reinert P, Lenoir G, Lesure JF, Rousset JP, Edelman A.

BMC Med. 2018 Aug 25;16(1):159. doi: 10.1186/s12916-018-1138-z.

5.

Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma.

Rollet-Cohen V, Bourderioux M, Lipecka J, Chhuon C, Jung VA, Mesbahi M, Nguyen-Khoa T, Guérin-Pfyffer S, Schmitt A, Edelman A, Sermet-Gaudelus I, Guerrera IC.

J Proteomics. 2018 Aug 15;185:1-7. doi: 10.1016/j.jprot.2018.07.001. Epub 2018 Jul 3.

PMID:
30032860
6.

Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons.

Pranke I, Bidou L, Martin N, Blanchet S, Hatton A, Karri S, Cornu D, Costes B, Chevalier B, Tondelier D, Girodon E, Coupet M, Edelman A, Fanen P, Namy O, Sermet-Gaudelus I, Hinzpeter A.

ERJ Open Res. 2018 Feb 23;4(1). pii: 00080-2017. doi: 10.1183/23120541.00080-2017. eCollection 2018 Jan. Erratum in: ERJ Open Res. 2018 Jul 13;4(3):.

7.

Cis variants identified in F508del complex alleles modulate CFTR channel rescue by small molecules.

Baatallah N, Bitam S, Martin N, Servel N, Costes B, Mekki C, Chevalier B, Pranke I, Simonin J, Girodon E, Hoffmann B, Mornon JP, Callebaut I, Sermet-Gaudelus I, Fanen P, Edelman A, Hinzpeter A.

Hum Mutat. 2018 Apr;39(4):506-514. doi: 10.1002/humu.23389. Epub 2018 Jan 16.

PMID:
29271547
8.

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway.

Saint-Criq V, Villeret B, Bastaert F, Kheir S, Hatton A, Cazes A, Xing Z, Sermet-Gaudelus I, Garcia-Verdugo I, Edelman A, Sallenave JM.

Thorax. 2018 Jan;73(1):49-61. doi: 10.1136/thoraxjnl-2017-210298. Epub 2017 Aug 8.

9.

Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators.

Pranke IM, Hatton A, Simonin J, Jais JP, Le Pimpec-Barthes F, Carsin A, Bonnette P, Fayon M, Stremler-Le Bel N, Grenet D, Thumerel M, Mazenq J, Urbach V, Mesbahi M, Girodon-Boulandet E, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

Sci Rep. 2017 Aug 7;7(1):7375. doi: 10.1038/s41598-017-07504-1.

10.

Impact of Cystinosin Glycosylation on Protein Stability by Differential Dynamic Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC).

Nevo N, Thomas L, Chhuon C, Andrzejewska Z, Lipecka J, Guillonneau F, Bailleux A, Edelman A, Antignac C, Guerrera IC.

Mol Cell Proteomics. 2017 Mar;16(3):457-468. doi: 10.1074/mcp.M116.063867. Epub 2017 Jan 12.

11.

New insights into interactions between the nucleotide-binding domain of CFTR and keratin 8.

Premchandar A, Kupniewska A, Bonna A, Faure G, Fraczyk T, Roldan A, Hoffmann B, Faria da Cunha M, Herrmann H, Lukacs GL, Edelman A, Dadlez M.

Protein Sci. 2017 Feb;26(2):343-354. doi: 10.1002/pro.3086.

12.

Analysis of nasal potential in murine cystic fibrosis models.

da Cunha MF, Simonin J, Sassi A, Freund R, Hatton A, Cottart CH, Elganfoud N, Zoubairi R, Dragu C, Jais JP, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

Int J Biochem Cell Biol. 2016 Nov;80:87-97. doi: 10.1016/j.biocel.2016.10.001. Epub 2016 Oct 4. Review.

PMID:
27717840
13.

Dataset of differential lipid raft and global proteomes of SILAC-labeled cystic fibrosis cells upon TNF -α stimulation.

Chhuon C, Pranke I, Borot F, Tondelier D, Lipecka J, Fritsch J, Chanson M, Edelman A, Ollero M, Guerrera IC.

Data Brief. 2016 Aug 20;9:51-6. doi: 10.1016/j.dib.2016.08.012. eCollection 2016 Dec.

14.

Changes in lipid raft proteome upon TNF-α stimulation of cystic fibrosis cells.

Chhuon C, Pranke I, Borot F, Tondelier D, Lipecka J, Fritsch J, Chanson M, Edelman A, Ollero M, Guerrera IC.

J Proteomics. 2016 Aug 11;145:246-253. doi: 10.1016/j.jprot.2016.07.003. Epub 2016 Jul 7.

PMID:
27397611
15.

Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis.

Faure G, Bakouh N, Lourdel S, Odolczyk N, Premchandar A, Servel N, Hatton A, Ostrowski MK, Xu H, Saul FA, Moquereau C, Bitam S, Pranke I, Planelles G, Teulon J, Herrmann H, Roldan A, Zielenkiewicz P, Dadlez M, Lukacs GL, Sermet-Gaudelus I, Ollero M, Corringer PJ, Edelman A.

J Mol Biol. 2016 Jul 17;428(14):2898-915. doi: 10.1016/j.jmb.2016.05.016. Epub 2016 May 27.

PMID:
27241308
16.

Sensitivity of mass spectrometry analysis depends on the shape of the filtration unit used for filter aided sample preparation (FASP).

Lipecka J, Chhuon C, Bourderioux M, Bessard MA, van Endert P, Edelman A, Guerrera IC.

Proteomics. 2016 Jul;16(13):1852-7. doi: 10.1002/pmic.201600103.

PMID:
27219663
17.

Genetic deletion of keratin 8 corrects the altered bone formation and osteopenia in a mouse model of cystic fibrosis.

Le Henaff C, Faria Da Cunha M, Hatton A, Tondelier D, Marty C, Collet C, Zarka M, Geoffroy V, Zatloukal K, Laplantine E, Edelman A, Sermet-Gaudelus I, Marie PJ.

Hum Mol Genet. 2016 Apr 1;25(7):1281-93. doi: 10.1093/hmg/ddw009. Epub 2016 Jan 13.

PMID:
26769674
18.

An unexpected effect of TNF-α on F508del-CFTR maturation and function.

Bitam S, Pranke I, Hollenhorst M, Servel N, Moquereau C, Tondelier D, Hatton A, Urbach V, Sermet-Gaudelus I, Hinzpeter A, Edelman A.

Version 2. F1000Res. 2015 Jul 10 [revised 2015 Jan 1];4:218. doi: 10.12688/f1000research.6683.2. eCollection 2015.

19.

rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.

Vidović D, Carlon MS, da Cunha MF, Dekkers JF, Hollenhorst MI, Bijvelds MJ, Ramalho AS, Van den Haute C, Ferrante M, Baekelandt V, Janssens HM, De Boeck K, Sermet-Gaudelus I, de Jonge HR, Gijsbers R, Beekman JM, Edelman A, Debyser Z.

Am J Respir Crit Care Med. 2016 Feb 1;193(3):288-98. doi: 10.1164/rccm.201505-0914OC.

PMID:
26509335
20.

Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25-28 March 2015.

Verkman AS, Edelman A, Amaral M, Mall MA, Beekman JM, Meiners T, Galietta LJ, Bear CE.

J Cyst Fibros. 2015 Nov;14(6):700-5. doi: 10.1016/j.jcf.2015.10.001. Epub 2015 Oct 21. No abstract available.

21.

Analysis of distinct molecular assembly complexes of keratin K8 and K18 by hydrogen-deuterium exchange.

Premchandar A, Kupniewska A, Tarnowski K, Mücke N, Mauermann M, Kaus-Drobek M, Edelman A, Herrmann H, Dadlez M.

J Struct Biol. 2015 Dec;192(3):426-440. doi: 10.1016/j.jsb.2015.10.001. Epub 2015 Oct 3.

PMID:
26434626
22.

Liposome-based Formulation for Intracellular Delivery of Functional Proteins.

Chatin B, Mével M, Devallière J, Dallet L, Haudebourg T, Peuziat P, Colombani T, Berchel M, Lambert O, Edelman A, Pitard B.

Mol Ther Nucleic Acids. 2015 Jun 23;4:e244. doi: 10.1038/mtna.2015.17.

23.

The hsa-miR-125a/hsa-let-7e/hsa-miR-99b cluster is potentially implicated in Cystic Fibrosis pathogenesis.

Endale Ahanda ML, Bienvenu T, Sermet-Gaudelus I, Mazzolini L, Edelman A, Zoorob R, Davezac N.

J Cyst Fibros. 2015 Sep;14(5):571-9. doi: 10.1016/j.jcf.2015.02.011. Epub 2015 Mar 21.

24.

A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients.

Bourderioux M, Nguyen-Khoa T, Chhuon C, Jeanson L, Tondelier D, Walczak M, Ollero M, Bekri S, Knebelmann B, Escudier E, Escudier B, Edelman A, Guerrera IC.

J Proteome Res. 2015 Jan 2;14(1):567-77. doi: 10.1021/pr501003q. Epub 2014 Nov 12.

PMID:
25365230
25.

Proteomic analysis of nasal epithelial cells from cystic fibrosis patients.

Jeanson L, Guerrera IC, Papon JF, Chhuon C, Zadigue P, Prulière-Escabasse V, Amselem S, Escudier E, Coste A, Edelman A.

PLoS One. 2014 Sep 30;9(9):e108671. doi: 10.1371/journal.pone.0108671. eCollection 2014.

26.

Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity.

He C, Gouble A, Bourdel A, Manchev V, Poirot L, Paques F, Duchateau P, Edelman A, Danos O.

Gene Ther. 2014 Aug;21(8):759-66. doi: 10.1038/gt.2014.51. Epub 2014 Jun 12.

PMID:
24919419
27.

Cystic fibrosis, a multi-systemic mucosal disease: 25 years after the discovery of CFTR.

Edelman A, Sallenave JM.

Int J Biochem Cell Biol. 2014 Jul;52:2-4. doi: 10.1016/j.biocel.2014.04.006. Epub 2014 Apr 13. No abstract available.

PMID:
24735713
28.

Cytoskeleton and CFTR.

Edelman A.

Int J Biochem Cell Biol. 2014 Jul;52:68-72. doi: 10.1016/j.biocel.2014.03.018. Epub 2014 Mar 28. Review.

PMID:
24685681
29.

Localized lipidomics in cystic fibrosis: TOF-SIMS imaging of lungs from Pseudomonas aeruginosa-infected mice.

Desbenoit N, Saussereau E, Bich C, Bourderioux M, Fritsch J, Edelman A, Brunelle A, Ollero M.

Int J Biochem Cell Biol. 2014 Jul;52:77-82. doi: 10.1016/j.biocel.2014.01.026. Epub 2014 Feb 7.

PMID:
24513532
30.

Regulation of interleukin-6 in head and neck squamous cell carcinoma is related to papillomavirus infection.

Guerrera IC, Quetier I, Fetouchi R, Moreau F, Vauloup-Fellous C, Lekbaby B, Rousselot C, Chhuon C, Edelman A, Lefevre M, Nicolas JC, Kremsdorf D, Lacau Saint Guily J, Soussan P.

J Proteome Res. 2014 Feb 7;13(2):1002-11. doi: 10.1021/pr401009f. Epub 2014 Jan 10.

PMID:
24405156
31.

Characterization of SLC26A9 in patients with CF-like lung disease.

Bakouh N, Bienvenu T, Thomas A, Ehrenfeld J, Liote H, Roussel D, Duquesnoy P, Farman N, Viel M, Cherif-Zahar B, Amselem S, Taam RA, Edelman A, Planelles G, Sermet-Gaudelus I.

Hum Mutat. 2013 Oct;34(10):1404-14. doi: 10.1002/humu.22382. Epub 2013 Aug 13.

PMID:
24272871
32.

Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.

Nikolov IG, Joki N, Galmiche A, Nguyen-Khoa T, Guerrera IC, Guillonneau F, Ivanovski O, Phan O, Maizel J, Marçon F, Benchitrit J, Lucas A, Edelman A, Lacour B, Drüeke TB, Massy ZA.

Atherosclerosis. 2013 Jul;229(1):42-51. doi: 10.1016/j.atherosclerosis.2013.02.041. Epub 2013 Apr 22.

PMID:
23672878
33.

Characterization of nasal potential difference in cftr knockout and F508del-CFTR mice.

Saussereau EL, Roussel D, Diallo S, Debarbieux L, Edelman A, Sermet-Gaudelus I.

PLoS One. 2013;8(3):e57317. doi: 10.1371/journal.pone.0057317. Epub 2013 Mar 7.

34.

Neutrophil elastase degrades cystic fibrosis transmembrane conductance regulator via calpains and disables channel function in vitro and in vivo.

Le Gars M, Descamps D, Roussel D, Saussereau E, Guillot L, Ruffin M, Tabary O, Hong SS, Boulanger P, Paulais M, Malleret L, Belaaouaj A, Edelman A, Huerre M, Chignard M, Sallenave JM.

Am J Respir Crit Care Med. 2013 Jan 15;187(2):170-9. doi: 10.1164/rccm.201205-0875OC. Epub 2012 Dec 6.

PMID:
23220915
35.

Small-molecule inhibitors of the cystic fibrosis transmembrane conductance regulator increase pancreatic endocrine cell development in rat and mouse.

Zertal-Zidani S, Busiah K, Edelman A, Polak M, Scharfmann R.

Diabetologia. 2013 Feb;56(2):330-9. doi: 10.1007/s00125-012-2778-8. Epub 2012 Nov 24.

36.

[Cystic fibrosis and other channelopathies].

Edelman A, Saussereau E.

Arch Pediatr. 2012 May;19 Suppl 1:S13-6. doi: 10.1016/S0929-693X(12)71101-6. Review. French.

PMID:
22682482
37.

Functional interaction between CFTR and the sodium-phosphate co-transport type 2a in Xenopus laevis oocytes.

Bakouh N, Chérif-Zahar B, Hulin P, Prié D, Friedlander G, Edelman A, Planelles G.

PLoS One. 2012;7(4):e34879. doi: 10.1371/journal.pone.0034879. Epub 2012 Apr 13.

38.

Long-term CFTR inhibition modulates 15d-prostaglandin J2 in human pulmonary cells.

Baudouin-Legros M, Colas J, Moriceau S, Kelly M, Planelles G, Edelman A, Ollero M.

Int J Biochem Cell Biol. 2012 Jun;44(6):1009-18. doi: 10.1016/j.biocel.2012.03.010. Epub 2012 Mar 28.

PMID:
22481026
39.

Oxidative stress induces unfolding protein response and inflammation in nasal polyposis.

Jeanson L, Kelly M, Coste A, Guerrera IC, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, Papon JF, Zadigue P, Prulière-Escabasse V, Amselem S, Escudier E, Edelman A.

Allergy. 2012 Mar;67(3):403-12. doi: 10.1111/j.1398-9995.2011.02769.x. Epub 2011 Dec 22.

PMID:
22188019
40.

The testis anion transporter TAT1 (SLC26A8) physically and functionally interacts with the cystic fibrosis transmembrane conductance regulator channel: a potential role during sperm capacitation.

Rode B, Dirami T, Bakouh N, Rizk-Rabin M, Norez C, Lhuillier P, Lorès P, Jollivet M, Melin P, Zvetkova I, Bienvenu T, Becq F, Planelles G, Edelman A, Gacon G, Touré A.

Hum Mol Genet. 2012 Mar 15;21(6):1287-98. doi: 10.1093/hmg/ddr558. Epub 2011 Nov 25.

PMID:
22121115
41.

Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect.

Colas J, Faure G, Saussereau E, Trudel S, Rabeh WM, Bitam S, Guerrera IC, Fritsch J, Sermet-Gaudelus I, Davezac N, Brouillard F, Lukacs GL, Herrmann H, Ollero M, Edelman A.

Hum Mol Genet. 2012 Feb 1;21(3):623-34. doi: 10.1093/hmg/ddr496. Epub 2011 Oct 28.

42.

Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.

Nikolov IG, Joki N, Nguyen-Khoa T, Guerrera IC, Maizel J, Benchitrit J, Machado dos Reis L, Edelman A, Lacour B, Jorgetti V, Drüeke TB, Massy ZA.

Nephrol Dial Transplant. 2012 Feb;27(2):505-13. doi: 10.1093/ndt/gfr254. Epub 2011 Jun 24.

PMID:
21705467
43.

New lipidomic approaches in cystic fibrosis.

Ollero M, Guerrera IC, Astarita G, Piomelli D, Edelman A.

Methods Mol Biol. 2011;742:265-78. doi: 10.1007/978-1-61779-120-8_16.

PMID:
21547738
44.

Quantitative differential proteomics of cystic fibrosis cell models by SILAC (stable isotope labelling in cell culture).

Guerrera IC, Ollero M, Vieu DL, Edelman A.

Methods Mol Biol. 2011;742:213-25. doi: 10.1007/978-1-61779-120-8_13.

PMID:
21547735
45.

GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models.

Kelly-Aubert M, Trudel S, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, Moriceau S, Jeanson L, Djouadi F, Matar C, Conti M, Ollero M, Brouillard F, Edelman A.

Hum Mol Genet. 2011 Jul 15;20(14):2745-59. doi: 10.1093/hmg/ddr173. Epub 2011 Apr 25.

PMID:
21518732
46.

Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1.

Hamdaoui N, Baudoin-Legros M, Kelly M, Aissat A, Moriceau S, Vieu DL, Colas J, Fritsch J, Edelman A, Planelles G.

Br J Pharmacol. 2011 Jun;163(4):876-86. doi: 10.1111/j.1476-5381.2011.01289.x.

47.

Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients.

Ollero M, Astarita G, Guerrera IC, Sermet-Gaudelus I, Trudel S, Piomelli D, Edelman A.

J Lipid Res. 2011 May;52(5):1011-22. doi: 10.1194/jlr.P013722. Epub 2011 Feb 18.

48.

Lipid mapping of colonic mucosa by cluster TOF-SIMS imaging and multivariate analysis in cftr knockout mice.

Brulet M, Seyer A, Edelman A, Brunelle A, Fritsch J, Ollero M, Laprévote O.

J Lipid Res. 2010 Oct;51(10):3034-45. doi: 10.1194/jlr.M008870. Epub 2010 Jul 8.

49.

Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.

Sermet-Gaudelus I, Girodon E, Sands D, Stremmler N, Vavrova V, Deneuville E, Reix P, Bui S, Huet F, Lebourgeois M, Munck A, Iron A, Skalicka V, Bienvenu T, Roussel D, Lenoir G, Bellon G, Sarles J, Macek M, Roussey M, Fajac I, Edelman A.

Am J Respir Crit Care Med. 2010 Oct 1;182(7):929-36. doi: 10.1164/rccm.201003-0382OC. Epub 2010 Jun 10.

PMID:
20538955
50.

Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.

Sermet-Gaudelus I, Girodon E, Roussel D, Deneuville E, Bui S, Huet F, Guillot M, Aboutaam R, Renouil M, Munck A, des Georges M, Iron A, Thauvin-Robinet C, Fajac I, Lenoir G, Roussey M, Edelman A.

Thorax. 2010 Jun;65(6):539-44. doi: 10.1136/thx.2009.123422.

PMID:
20522854
51.

Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition.

Kelly M, Trudel S, Brouillard F, Bouillaud F, Colas J, Nguyen-Khoa T, Ollero M, Edelman A, Fritsch J.

J Pharmacol Exp Ther. 2010 Apr;333(1):60-9. doi: 10.1124/jpet.109.162032. Epub 2010 Jan 5.

52.

A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.

Guerrera IC, Astarita G, Jais JP, Sands D, Nowakowska A, Colas J, Sermet-Gaudelus I, Schuerenberg M, Piomelli D, Edelman A, Ollero M.

PLoS One. 2009 Nov 6;4(11):e7735. doi: 10.1371/journal.pone.0007735.

53.

Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells.

Borot F, Vieu DL, Faure G, Fritsch J, Colas J, Moriceau S, Baudouin-Legros M, Brouillard F, Ayala-Sanmartin J, Touqui L, Chanson M, Edelman A, Ollero M.

PLoS One. 2009 Oct 22;4(10):e7116. doi: 10.1371/journal.pone.0007116.

54.

Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge.

Trudel S, Kelly M, Fritsch J, Nguyen-Khoa T, Thérond P, Couturier M, Dadlez M, Debski J, Touqui L, Vallée B, Ollero M, Edelman A, Brouillard F.

PLoS One. 2009 Jun 29;4(6):e6075. doi: 10.1371/journal.pone.0006075.

55.

[Novel therapies for cystic fibrosis in 2009].

Sermet-Gaudelus I, Le Bourgeois M, Edelman A, Lenoir G.

Arch Pediatr. 2009 Jun;16(6):578-80. doi: 10.1016/S0929-693X(09)74073-4. French. No abstract available.

PMID:
19541091
56.

Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients.

Moriceau S, Kantari C, Mocek J, Davezac N, Gabillet J, Guerrera IC, Brouillard F, Tondelier D, Sermet-Gaudelus I, Danel C, Lenoir G, Daniel S, Edelman A, Witko-Sarsat V.

J Immunol. 2009 Jun 1;182(11):7254-63. doi: 10.4049/jimmunol.0803312.

57.

Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology.

Brouillard F, Fritsch J, Edelman A, Ollero M.

Proteomics Clin Appl. 2008 Feb;2(2):264-85. doi: 10.1002/prca.200780018.

PMID:
21136830
58.

Control of basal CFTR gene expression by bicarbonate-sensitive adenylyl cyclase in human pulmonary cells.

Baudouin-Legros M, Hamdaoui N, Borot F, Fritsch J, Ollero M, Planelles G, Edelman A.

Cell Physiol Biochem. 2008;21(1-3):75-86. doi: 10.1159/000113749. Epub 2008 Jan 16.

59.

In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.

Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, Davy N, Bismuth E, Reinert P, Lenoir G, Lesure JF, Rousset JP, Edelman A.

BMC Med. 2007 Mar 29;5:5. Erratum in: BMC Med. 2018 Aug 25;16(1):159.

60.

High sensitivity identification of membrane proteins by MALDI TOF-MASS spectrometry using polystyrene beads.

Bensalem N, Masscheleyn S, Mozo J, Vallée B, Brouillard F, Trudel S, Ricquier D, Edelman A, Guerrera IC, Miroux B.

J Proteome Res. 2007 Apr;6(4):1595-602. Epub 2007 Mar 14.

PMID:
17355127
61.

Membrane cholesterol content modulates ClC-2 gating and sensitivity to oxidative stress.

Hinzpeter A, Fritsch J, Borot F, Trudel S, Vieu DL, Brouillard F, Baudouin-Legros M, Clain J, Edelman A, Ollero M.

J Biol Chem. 2007 Jan 26;282(4):2423-32. Epub 2006 Nov 15.

62.

The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.

Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A.

BMC Pediatr. 2006 Oct 3;6:25.

63.

Cystic fibrosis enters the proteomics scene: new answers to old questions.

Ollero M, Brouillard F, Edelman A.

Proteomics. 2006 Jul;6(14):4084-99. Review.

PMID:
16791827
64.

Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.

Lipecka J, Norez C, Bensalem N, Baudouin-Legros M, Planelles G, Becq F, Edelman A, Davezac N.

J Pharmacol Exp Ther. 2006 May;317(2):500-5. Epub 2006 Jan 19.

65.

Blue native/SDS-PAGE analysis reveals reduced expression of the mClCA3 protein in cystic fibrosis knock-out mice.

Brouillard F, Bensalem N, Hinzpeter A, Tondelier D, Trudel S, Gruber AD, Ollero M, Edelman A.

Mol Cell Proteomics. 2005 Nov;4(11):1762-75. Epub 2005 Aug 11.

66.

Association between Hsp90 and the ClC-2 chloride channel upregulates channel function.

Hinzpeter A, Lipecka J, Brouillard F, Baudoin-Legros M, Dadlez M, Edelman A, Fritsch J.

Am J Physiol Cell Physiol. 2006 Jan;290(1):C45-56. Epub 2005 Jul 27.

67.

Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients.

Bensalem N, Ventura AP, Vallée B, Lipecka J, Tondelier D, Davezac N, Dos Santos A, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure JF, Halgand F, Laprévote O, Edelman A.

Mol Cell Proteomics. 2005 Oct;4(10):1591-601. Epub 2005 Jul 12.

68.

Cell-specific posttranscriptional regulation of CFTR gene expression via influence of MAPK cascades on 3'UTR part of transcripts.

Baudouin-Legros M, Hinzpeter A, Jaulmes A, Brouillard F, Costes B, Fanen P, Edelman A.

Am J Physiol Cell Physiol. 2005 Nov;289(5):C1240-50. Epub 2005 Jun 8.

69.

Expression of the human erythroid Rh glycoprotein (RhAG) enhances both NH3 and NH4+ transport in HeLa cells.

Benjelloun F, Bakouh N, Fritsch J, Hulin P, Lipecka J, Edelman A, Planelles G, Thomas SR, Chérif-Zahar B.

Pflugers Arch. 2005 Jun;450(3):155-67. Epub 2005 Apr 26.

PMID:
15856280
70.

Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype.

Clain J, Lehmann-Che J, Duguépéroux I, Arous N, Girodon E, Legendre M, Goossens M, Edelman A, de Braekeleer M, Teulon J, Fanen P.

Hum Mutat. 2005 Apr;25(4):360-71.

PMID:
15776432
71.

A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype.

Clain J, Lehmann-Che J, Girodon E, Lipecka J, Edelman A, Goossens M, Fanen P.

Hum Genet. 2005 May;116(6):454-60. Epub 2005 Mar 3.

PMID:
15744523
72.

Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.

Sermet-Gaudelus I, Déchaux M, Vallée B, Fajac A, Girodon E, Nguyen-Khoa T, Marianovski R, Hurbain I, Bresson JL, Lenoir G, Edelman A.

Am J Respir Crit Care Med. 2005 May 1;171(9):1026-31. Epub 2005 Feb 11.

PMID:
15709055
73.

Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/deltaF508-CFTR to the plasma membrane.

Davezac N, Tondelier D, Lipecka J, Fanen P, Demaugre F, Debski J, Dadlez M, Schrattenholz A, Cahill MA, Edelman A.

Proteomics. 2004 Dec;4(12):3833-44.

PMID:
15529338
74.

Microelectrodes and their use to assess ion channel function.

Edelman A, Chanson M, Hug MJ.

J Cyst Fibros. 2004 Aug;3 Suppl 2:113-7. Review.

75.

TGF-beta 1 downregulates CFTR expression and function in nasal polyps of non-CF patients.

Prulière-Escabasse V, Fanen P, Dazy AC, Lechapt-Zalcman E, Rideau D, Edelman A, Escudier E, Coste A.

Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L77-83. Epub 2004 Sep 10.

76.

NH3 is involved in the NH4+ transport induced by the functional expression of the human Rh C glycoprotein.

Bakouh N, Benjelloun F, Hulin P, Brouillard F, Edelman A, Chérif-Zahar B, Planelles G.

J Biol Chem. 2004 Apr 16;279(16):15975-83. Epub 2004 Feb 3.

77.

Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the delta F508 mutation.

Hurbain I, Sermet-Gaudelus I, Vallee B, Feuillet MN, Lenoir G, Bernaudin JF, Edelman A, Fajac A.

Pediatr Res. 2003 Nov;54(5):627-34. Epub 2003 Aug 20.

PMID:
12930913
78.

Effect of ouabain on CFTR gene expression in human Calu-3 cells.

Baudouin-Legros M, Brouillard F, Tondelier D, Hinzpeter A, Edelman A.

Am J Physiol Cell Physiol. 2003 Mar;284(3):C620-6.

79.

Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.

Sermet-Gaudelus I, Vallée B, Urbin I, Torossi T, Marianovski R, Fajac A, Feuillet MN, Bresson JL, Lenoir G, Bernaudin JF, Edelman A.

Pediatr Res. 2002 Nov;52(5):628-35.

PMID:
12409506
80.

Distribution of ClC-2 chloride channel in rat and human epithelial tissues.

Lipecka J, Bali M, Thomas A, Fanen P, Edelman A, Fritsch J.

Am J Physiol Cell Physiol. 2002 Apr;282(4):C805-16.

81.

Regulation of ClC-2 chloride channels in T84 cells by TGF-alpha.

Bali M, Lipecka J, Edelman A, Fritsch J.

Am J Physiol Cell Physiol. 2001 Jun;280(6):C1588-98.

82.

Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.

Brouillard F, Tondelier D, Edelman A, Baudouin-Legros M.

Cancer Res. 2001 Feb 15;61(4):1693-8.

83.

Functional cystic fibrosis transmembrane conductance regulator tagged with an epitope of the vesicular stomatis virus glycoprotein can be addressed to the apical domain of polarized cells.

Costa de Beauregard MA, Edelman A, Chesnoy-Marchais D, Tondelier D, Lapillonne A, El Marjou F, Robine S, Louvard D.

Eur J Cell Biol. 2000 Nov;79(11):795-802.

PMID:
11139142
84.
85.

NF-kappa B mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1beta.

Brouillard F, Bouthier M, Leclerc T, Clement A, Baudouin-Legros M, Edelman A.

J Biol Chem. 2001 Mar 23;276(12):9486-91. Epub 2000 Dec 12.

86.

Identification of a novel mutation, 1087delT, in exon 7 of the CFTR gene in a patient with cystic fibrosis.

Feuillet-Fieux MN, Sermet I, Edelman A, Torossi T, Ferrec M, Guillot M, Lenoir G, Bonnefont JP, Thuillier L.

Hum Mutat. 2000 Jul;16(1):95. No abstract available.

PMID:
10874326
87.

Aspirin and some other nonsteroidal anti-inflammatory drugs inhibit cystic fibrosis transmembrane conductance regulator protein gene expression in T-84 cells.

Tondelier D, Brouillard F, Lipecka J, Labarthe R, Bali M, Costa de Beauregard MA, Torossi T, Cougnon M, Edelman A, Baudouin-Legros M.

Mediators Inflamm. 1999;8(4-5):219-27.

88.

Modulation of CFTR gene expression in HT-29 cells by extracellular hyperosmolarity.

Baudouin-Legros M, Brouillard F, Cougnon M, Tondelier D, Leclerc T, Edelman A.

Am J Physiol Cell Physiol. 2000 Jan;278(1):C49-56.

89.

Ammonium transport by the colonic H(+)-K(+)-ATPase expressed in Xenopus oocytes.

Cougnon M, Bouyer P, Jaisser F, Edelman A, Planelles G.

Am J Physiol. 1999 Aug;277(2):C280-7. doi: 10.1152/ajpcell.1999.277.2.C280.

PMID:
10444404
90.

Structure-function analysis of a double-mutant cystic fibrosis transmembrane conductance regulator protein occurring in disorders related to cystic fibrosis.

Fanen P, Clain J, Labarthe R, Hulin P, Girodon E, Pagesy P, Goossens M, Edelman A.

FEBS Lett. 1999 Jun 11;452(3):371-4.

91.

New sequence-specific human ribonuclease: purification and properties.

Przewlocki G, Lipecka J, Edelman A, Przykorska A.

Nucleic Acids Res. 1998 Sep 1;26(17):4047-55.

92.
94.

Osmosensitivity of the hyperpolarization-activated chloride current in human intestinal T84 cells.

Fritsch J, Edelman A.

Am J Physiol. 1997 Mar;272(3 Pt 1):C778-86.

PMID:
9124511
95.

Partial purification of the pig kidney cystic fibrosis transmembrane regulator protein.

Benharouga M, Fritsch J, Goossens M, Edelman A.

C R Acad Sci III. 1996 Nov;319(11):1019-25.

PMID:
9033846
96.

Properties of a Cl(-)-conductive pathway(s) in microsomes from rat kidney inner medulla. Involvement of cystic fibrosis transmembrane regulator protein.

Benharouga M, Lipecka J, Fanen P, Baudoin-Legros M, Banting G, Fritsch J, Edelman A.

Eur J Biochem. 1996 Aug 15;240(1):268-73.

98.

Interferon-gamma downregulates CFTR gene expression in epithelial cells.

Besançon F, Przewlocki G, Baró I, Hongre AS, Escande D, Edelman A.

Am J Physiol. 1994 Nov;267(5 Pt 1):C1398-404.

PMID:
7526699
99.

ATP-regulated chloride conductance in endoplasmic reticulum (ER)-enriched pig pancreas microsomes.

Bégault B, Anagnostopoulos T, Edelman A.

Biochim Biophys Acta. 1993 Nov 7;1152(2):319-27.

PMID:
8218333
100.

A nucleotide-regulated Cl-/OH- anion exchanger in endoplasmic reticulum-enriched pig pancreatic microsomes.

Bégault B, Edelman A.

Biochim Biophys Acta. 1993 Mar 14;1146(2):183-90.

PMID:
8452854
101.

Millimolar amiloride concentrations block K conductance in proximal tubular cells.

Discala F, Hulin P, Belachgar F, Planelles G, Edelman A, Anagnostopoulos T.

Br J Pharmacol. 1992 Oct;107(2):532-8.

102.

Inducible Secretion of a Cellulase from Clostridium thermocellum in Bacillus subtilis.

Joliff G, Edelman A, Klier A, Rapoport G.

Appl Environ Microbiol. 1989 Nov;55(11):2739-44.

103.

Corticosteroid-induced changes in the responsiveness of human osteoblast-like cells to parathyroid hormone.

Silve C, Fritsch J, Grosse B, Tau C, Edelman A, Delmas P, Balsan S, Garabedian M.

Bone Miner. 1989 Apr;6(1):65-75.

PMID:
2546639
104.
105.

Comparative studies of membrane potentials of rat osteoblasts in situ and in primary culture.

Fritsch J, Edelman A, Balsan S.

Bone Miner. 1987 Sep;2(6):463-78.

PMID:
3505769

Supplemental Content

Loading ...
Support Center